Abigail Kroch

586 total citations
29 papers, 170 citations indexed

About

Abigail Kroch is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Abigail Kroch has authored 29 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 16 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Abigail Kroch's work include HIV/AIDS Research and Interventions (18 papers), HIV, Drug Use, Sexual Risk (11 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Abigail Kroch is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), HIV, Drug Use, Sexual Risk (11 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Abigail Kroch collaborates with scholars based in Canada, United States and United Kingdom. Abigail Kroch's co-authors include Karen G. Fleming, James Wilton, Diana Martins, Tara Gomes, Darrell H. S. Tan, Ann N. Burchell, Lucia Light, Curtis Cooper, Mona Loutfy and Patrick O’Byrne and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Vaccine.

In The Last Decade

Abigail Kroch

25 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abigail Kroch Canada 8 101 88 27 24 22 29 170
Víctor Hontañón Spain 11 108 1.1× 195 2.2× 15 0.6× 40 1.7× 5 0.2× 28 297
Kelly A. Hennessey United States 4 184 1.8× 126 1.4× 22 0.8× 6 0.3× 5 0.2× 4 225
Mônica Baumgardt Bay Brazil 8 179 1.8× 133 1.5× 7 0.3× 15 0.6× 12 0.5× 13 215
James B. Brock United States 11 182 1.8× 115 1.3× 65 2.4× 7 0.3× 2 0.1× 29 271
Kelly E. Perry United States 11 120 1.2× 37 0.4× 21 0.8× 94 3.9× 4 0.2× 23 314
Liangui Feng China 10 255 2.5× 250 2.8× 78 2.9× 26 1.1× 3 0.1× 22 362
Wuraola A. Shokunbi Nigeria 11 34 0.3× 23 0.3× 22 0.8× 29 1.2× 6 0.3× 22 350
Lorena de la Mora Spain 9 182 1.8× 71 0.8× 10 0.4× 13 0.5× 32 239
Mamadou Cissé Mali 12 238 2.4× 59 0.7× 25 0.9× 35 1.5× 2 0.1× 23 336

Countries citing papers authored by Abigail Kroch

Since Specialization
Citations

This map shows the geographic impact of Abigail Kroch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail Kroch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail Kroch more than expected).

Fields of papers citing papers by Abigail Kroch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abigail Kroch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail Kroch. The network helps show where Abigail Kroch may publish in the future.

Co-authorship network of co-authors of Abigail Kroch

This figure shows the co-authorship network connecting the top 25 collaborators of Abigail Kroch. A scholar is included among the top collaborators of Abigail Kroch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abigail Kroch. Abigail Kroch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Curtis, Abigail Kroch, Rahim Moineddin, et al.. (2025). COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada. Vaccine. 61. 127422–127422.
2.
Wardell, Jeffrey D., et al.. (2024). Correlates of Using Medically-Authorized Cannabis in a Large Cohort of People Living with HIV Who Use Cannabis. AIDS and Behavior. 29(3). 858–869. 1 indexed citations
3.
4.
O’Byrne, Patrick, et al.. (2024). Targeted HIV Self-Testing Identifies Persons with Undiagnosed HIV and Active Engagement Links them to Care: The GetaKit Study. AIDS and Behavior. 28(6). 2015–2022. 3 indexed citations
5.
Puyat, Joseph H., James Wilton, Naveed Z. Janjua, et al.. (2023). COVID‐19 vaccine effectiveness by HIV status and history of injection drug use: a test‐negative analysis. Journal of the International AIDS Society. 26(10). e26178–e26178. 1 indexed citations
6.
7.
Kazemi, Mina, Stephanie Smith, Wangari Tharao, et al.. (2022). HIV care cascade for women living with HIV in the Greater Toronto Area versus the rest of Ontario and Canada. International Journal of STD & AIDS. 34(1). 4–17. 5 indexed citations
8.
Samji, Hasina, Joseph H. Puyat, Naveed Z. Janjua, et al.. (2022). Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design. International Journal of Infectious Diseases. 127. 162–170. 9 indexed citations
9.
Fredericksen, Rob J., Heidi M. Crane, Jean Bacon, et al.. (2022). Utility and Impact of the Implementation of Same-Day, Self-administered Electronic Patient-Reported Outcomes Assessments in Routine HIV Care in two North American Clinics. AIDS and Behavior. 26(7). 2409–2424. 14 indexed citations
10.
Loutfy, Mona, Curtis Cooper, Abigail Kroch, et al.. (2022). Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study. The Canadian Journal of Hospital Pharmacy. 75(4). 309–316. 1 indexed citations
11.
Chambers, Catharine, Jennifer Gillis, Anita C. Benoit, et al.. (2022). Low human papillomavirus vaccine uptake among women engaged in HIV care in Ontario, Canada. Preventive Medicine. 164. 107246–107246. 4 indexed citations
12.
Nicolau, Ioana, Tony Antoniou, Jennifer D. Brooks, et al.. (2022). The burden of cancer among people living with HIV in Ontario, Canada, 1997–2020: a retrospective population-based cohort study using administrative health data. CMAJ Open. 10(3). E666–E674. 5 indexed citations
13.
Grewal, Ramandip, Tony Mazzulli, Curtis Cooper, et al.. (2021). Hepatitis C virus testing in a clinical HIV cohort in Ontario, Canada, 2000 to 2015. Health Science Reports. 4(3). e358–e358. 3 indexed citations
14.
Lachowsky, Nathan J., Axel J. Schmidt, Barry D. Adam, et al.. (2021). Measures of HIV Pre-exposure Prophylaxis Uptake Among Gay, Bisexual, and Other Men Who Have Sex with Men in Canada and Demographic Disparities Among Those at Elevated Likelihood for HIV Acquisition. AIDS and Behavior. 25(11). 3638–3650. 7 indexed citations
15.
Mbuagbaw, Lawrence, Carmen H. Logie, Lehana Thabane, et al.. (2021). The impact of routine HIV drug resistance testing in Ontario: A controlled interrupted time series study. PLoS ONE. 16(4). e0246766–e0246766.
16.
Tan, Darrell H. S., et al.. (2020). Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015–2018). Canadian Journal of Public Health. 112(1). 89–96. 22 indexed citations
17.
Sereda, Paul, Erin Ding, Alex Wong, et al.. (2019). Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada. BMC Infectious Diseases. 19(1). 982–982. 9 indexed citations
18.
Wilton, James, Juan Liu, Beth Rachlis, et al.. (2019). Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study. PLoS ONE. 14(1). e0210096–e0210096. 18 indexed citations
19.
20.
Kroch, Abigail & Karen G. Fleming. (2006). Alternate Interfaces May Mediate Homomeric and Heteromeric Assembly in the Transmembrane Domains of SNARE Proteins. Journal of Molecular Biology. 357(1). 184–194. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctor Hontañón Breakdown of academic impact, for papers by Kelly A. Hennessey Breakdown of academic impact, for papers by Mônica Baumgardt Bay Breakdown of academic impact, for papers by James B. Brock Breakdown of academic impact, for papers by Kelly E. Perry Breakdown of academic impact, for papers by Liangui Feng Breakdown of academic impact, for papers by Wuraola A. Shokunbi Breakdown of academic impact, for papers by Lorena de la Mora Breakdown of academic impact, for papers by Mamadou Cissé
Rankless by CCL
2026